Tag Title: news


Sanofi considered moving headquarters abroad: report

November 4th, 2012

PARIS | Sun Nov 4, 2012 11:04am EST PARIS (Reuters) – Sanofi’s management considered moving its headquarters abroad in the last few months but the plan was nixed by the drugmaker’s chairman, French weekly Le Journal du Dimanche reported on Sunday, citing sources close to the board. First mooted in July, when the Socialist government was preparing to introduce a 75 percent tax on top earnings, the plan envisaged moving the headquarters to London or the United States, or at least relocating Chief Executive Chris Viehbacher and his closest associates abroad

[Continue Reading...]

Novo confident in heart safety of new insulin

October 26th, 2012

By Mette Fraende and Ole Mikkelsen COPENHAGEN | Fri Oct 26, 2012 7:23am EDT COPENHAGEN (Reuters) – Novo Nordisk said it was confident about the safety of new ultra long-acting insulin degludec, after news a U.S. panel is to examine its heart risks sent the Danish group’s shares lower

[Continue Reading...]

Novo shares drop on U.S. scrutiny of insulin drug

October 26th, 2012

COPENHAGEN | Fri Oct 26, 2012 4:26am EDT COPENHAGEN (Reuters) – Shares in Denmark’s Novo Nordisk fell as much as 5 percent on Friday, after a U.S.

[Continue Reading...]

Are cancer patients’ hopes for chemo too high?

October 24th, 2012

By Gene Emery NEW YORK | Wed Oct 24, 2012 5:07pm EDT NEW YORK (Reuters Health) – At least two thirds of people with advanced cancer in a new survey believed the chemotherapy they’re receiving might cure them, even though the treatment is only being given to buy some time or make them comfortable. “Their expectations are way out of line with reality,” Dr. Deborah Schrag of the Dana-Farber Cancer Institute in Boston told Reuters Health.

[Continue Reading...]

U.S. elderly, middle-aged see higher obesity rates: poll

October 24th, 2012

By Susan Heavey WASHINGTON | Wed Oct 24, 2012 11:30am EDT WASHINGTON (Reuters) – Here’s one more reason to dread aging: older Americans are seeing a greater increase in obesity rates, according to a survey released on Wednesday. Data from nearly 600,000 U.S

[Continue Reading...]

FDA probes deaths for links to Monster energy drink

October 22nd, 2012

Tweet Share this Email Print Two cans of Monster Energy drink are pictured in this photo-illustration shot in Los Angeles October 22,2012. Credit: Reuters/Fred Prouser By Martinne Geller Mon Oct 22, 2012 5:09pm EDT (Reuters) – The Food and Drug Administration said on Monday that it was investigating reports of five deaths that may be associated with Monster Beverage Corp’s energy drink, and the company’s shares fell more than 14 percent. Monster is also being sued by the family of a 14-year-old girl who died after drinking two cans of its Monster Energy drink in a 24-hour period.

[Continue Reading...]

Substance abuse diagnoses increasing in U.S.

October 22nd, 2012

By Andrew M. Seaman NEW YORK | Mon Oct 22, 2012 4:44pm EDT NEW YORK (Reuters Health) – Possibly driven by a surge in painkiller abuse, the number of drug and alcohol problems diagnosed by U.S.

[Continue Reading...]

Bayer lung drug shows promise in pulmonary hypertension

October 22nd, 2012

FRANKFURT | Mon Oct 22, 2012 12:01am EDT FRANKFURT (Reuters) – Bayer’s experimental riociguat pill showed promise against a life-threatening form of high blood pressure in the lungs, a potential challenge to existing treatments from Actelion and Gilead. In a late-stage trial, the drug helped people suffering from pulmonary arterial hypertension (PAH), a progressively worsening condition that can overburden the heart, to better tolerate physical exercise and improve heart function, Bayer said on Monday.

[Continue Reading...]

London sanitation show aims to make "poo" hot topic

October 18th, 2012

By Julie Mollins LONDON | Thu Oct 18, 2012 12:47pm EDT LONDON (Reuters) – Human defecation remains a taboo subject, despite the fact that 2.5 billion people lack toilets, causing a global health crisis that kills more than a million children each year. The London School of Hygiene & Tropical Medicine (LSHTM) hopes a new exhibition opening on Thursday will make sanitation easier to discuss

[Continue Reading...]

Severe obesity still rising fast in the U.S

October 18th, 2012

Women sit on a bench in New York’s Times Square May 31, 2012.

[Continue Reading...]




Cosmatic Surgery Procedures
Botox Injection
Breast Augmentation
Breast Augmentation – Saline Breast Implants
Breast Lift
Brow Lift
Buttock Implants with high cohesive gel
Chin Augmentation
Chin Reduction Reshaping (Genioplasty)
Dorsal Hump Correction
Double Eyelid Surgery
Endoscopic Brow Lift
Endoscopic Face Lift
Endoscopic Forehead Lift
Eyelid Surgery
Face Lift
Facial Feminization Surgery (FFS)
Facial Surgery
Fat Transfer
Gummy Bear – Cohesive Gel Breast Implants
Hair Transplant
Labia Surgery
Lip Augmentation
Lip Reduction
LipoSelection by Vaser
Liposuction
Liposuction with Body Jet (Water Assisted)
Mandible Angle Resection (Jaw and Chin Shaving) Surgery
Nasal Tip Rhinoplasty
Nose Augmentation – Fat Injection
Nose Augmentation – Rhinoplasty
Nose Surgery – Alarplasty
Otoplasty – Ear Surgery
Penis Enlargement Surgery Phalloplasty
Permanent Hair Removal
Restylane Injection
Rhinoplasty – Nose Surgery
Sex Change, Sex Reassignment Surgery
Silhouette Lift
Tummy Tuck
Vagina Tightening
Vaser High Definition Sculpting
 
 

 


Awarded by
WhatClinic.com
 

SP Clinic 1519/69-70 Ladproud 41/1 Samsennog Huaykuang Bangkok 10310, Thailand
Mobile Phone For English please call + 6681 915 1030
Tel. +662 9304450-5 Fax. +662 9399061
 
email: spsansiri@yahoo.com       drsompob@sp-cosmeticsurgery.net
 
Website Designed, and Developed by RedOnion Co.,Ltd.